Merrimack Pharmaceuticals Price Prediction
| MACKDelisted Stock | USD 11.96 0.12 1.01% |
Oversold Vs Overbought
30
Oversold | Overbought |
Using Merrimack Pharmaceuticals hype-based prediction, you can estimate the value of Merrimack Pharmaceuticals from the perspective of Merrimack Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Merrimack Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Merrimack because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Merrimack Pharmaceuticals after-hype prediction price | USD 11.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Merrimack |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Merrimack Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Merrimack Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Merrimack Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Merrimack Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Merrimack Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Merrimack Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Merrimack Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Merrimack Pharmaceuticals' historical news coverage. Merrimack Pharmaceuticals' after-hype downside and upside margins for the prediction period are 11.96 and 11.96, respectively. We have considered Merrimack Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Merrimack Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Merrimack Pharmaceuticals is based on 3 months time horizon.
Merrimack Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Merrimack Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merrimack Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Merrimack Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
11.96 | 11.96 | 0.00 |
|
Merrimack Pharmaceuticals Hype Timeline
Merrimack Pharmaceuticals is now traded for 11.96. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Merrimack is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Merrimack Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 11.96. About 63.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.07. Merrimack Pharmaceuticals recorded a loss per share of 0.09. The entity last dividend was issued on the 9th of May 2024. The firm had 1271:1000 split on the 6th of September 2019. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.Merrimack Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Merrimack Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Merrimack Pharmaceuticals' future price movements. Getting to know how Merrimack Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Merrimack Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FOLD | Amicus Therapeutics | (0.26) | 9 per month | 0.00 | (0.18) | 3.16 | (3.58) | 18.26 | |
| CLDX | Celldex Therapeutics | (1.53) | 10 per month | 0.00 | (0.14) | 5.77 | (6.76) | 19.39 | |
| ACHN | Achillion Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBYI | Puma Biotechnology | (0.02) | 8 per month | 4.69 | 0.02 | 5.17 | (5.38) | 33.65 | |
| AGIO | Agios Pharm | (0.31) | 8 per month | 2.44 | 0.06 | 5.24 | (4.04) | 15.93 |
Merrimack Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Merrimack price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Merrimack using various technical indicators. When you analyze Merrimack charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Merrimack Pharmaceuticals Predictive Indicators
The successful prediction of Merrimack Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Merrimack Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Merrimack Pharmaceuticals based on analysis of Merrimack Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Merrimack Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Merrimack Pharmaceuticals's related companies.
Story Coverage note for Merrimack Pharmaceuticals
The number of cover stories for Merrimack Pharmaceuticals depends on current market conditions and Merrimack Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Merrimack Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Merrimack Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Merrimack Pharmaceuticals Short Properties
Merrimack Pharmaceuticals' future price predictability will typically decrease when Merrimack Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Merrimack Pharmaceuticals often depends not only on the future outlook of the potential Merrimack Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Merrimack Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14.3 M | |
| Cash And Short Term Investments | 18.9 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |